Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02111200 · ClinicalTrials.gov registry record · NA
Comparative Efficacy of Phenylbutyrate (PBA) vs. Benzoate in Urea Cycle Disorders
A NA study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02111200 is a NA study that has completed, run by Baylor College of Medicine. The registered enrollment target is 7 participants.
The verdict
NCT02111200, a NA study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The investigators will study and compare how effectively sodium phenylbutyrate, sodium benzoate, and a combination of the two, help excrete nitrogen in healthy volunteers. Subject participation will require three, separate, four-day study periods at least one week apart. During one study period (also called a treatment arm), subjects will take sodium phenylbutyrate; during another they will take sodium benzoate; during another they will take a combination of the two medications. We expect to find that phenylbutyrate is more effective at removing nitrogen than benzoate or a combination of the two.
Interventions
- DRUG Sodium Phenylbutyrate
- DRUG Sodium Benzoate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02111200
The ClinicalTrials.gov registry entry for NCT02111200 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sodium Phenylbutyrate is the first listed.
NCT02111200 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02111200 about?
NCT02111200 is a clinical study titled "Comparative Efficacy of Phenylbutyrate (PBA) vs. Benzoate in Urea Cycle Disorders". The investigators will study and compare how effectively sodium phenylbutyrate, sodium benzoate, and a combination of the two, help excrete nitrogen in healthy volunteers. Subject participation will require three, separate, four-day study periods at least one week apart. During one study period (als...
What is the current status of trial NCT02111200?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2014-09. Estimated completion is 2015-10.
What interventions are being tested in trial NCT02111200?
The interventions under investigation include: Sodium Phenylbutyrate (DRUG), Sodium Benzoate (DRUG).
Who is sponsoring clinical trial NCT02111200?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.